Treatment outcomes of paul versus ahmed glaucoma implants
Both PGI and AGI effectively reduced IOP and the number of IOP-lowering eye drops over an 18-month follow-up period. The PGI demonstrated significantly greater reductions in IOP and IOP-lowering eye drops than AGI at 18 months. The safety profiles of PGI and AGI were comparable.
Authors
- Kira Hilmers
- Constance Liegl
- Peter Walter
- Verena Prokosch
- Karl Mercieca
- Julia Prinz
Institutions
- University of Bonn (DE)
- University Hospital Cologne (DE)
- RWTH Aachen University (DE)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1371/journal.pone.0338317
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00